NAS10028,385−3.46%S&P7,580−1.82%GOLD$3,914+0.38%BTC$77,790−0.59%VIX19.02−2.06%latest tape · as of 12:01 UTC
The Screen · Technology · Semiconductors
Credo Technology Group Holding Ltd
CRDO · NASDAQ · USD · Market cap $32.5B
Credo Technology Group Holding Ltd provides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.
FAIL · Does not pass the screen
150.99 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 12:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.56, read 2026-10-28
Ethical does not pass the values gate
Price150.99 USD
Fair value185.19
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Distribution150.99+0.0% to today Markdown gives way to Distribution after a 13% slide in 7 days
2026-10-25Read Markdown172.81-12.6% to today ✓Accumulation gives way to Markdown after a 10% slide in 2 weeks
2026-10-11Read Accumulation192.35-21.5% to today Distribution gives way to Accumulation
2026-10-02Read Distribution192.35-21.5% to today ✓Markup gives way to Distribution after a 23% slide in 13 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Credo Technology Group Holding Ltd holds its Distribution at $150.99. The statistical read favours the sellers, held for 7 days.
As held on the ledger · 2026-10-30
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 7 days
Price at the screen
$150.99
Valuation
61.28 trailing · 17.83 forward price to earnings
Values screen
FAIL· score 70.0
Beta
3.25
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
1.11%
Below 33%
Interest-bearing debt is just 1.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
12.12%
Below 33%
Cash held in interest-bearing accounts and securities is 12.1% of assets, under the one-third limit.
Pass
Receivables
60.91%
Below 49%
Money owed to the company is 60.9% of assets, above the 49% limit.
Fail
Revenue purity
2.34%
Below 5%
Only 2.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Credo Technology's business is fine, but its receivables are about 61% of its assets, well over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CRDO's ethical verdict changes
Today CRDO does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 22.7% margin of safety to the base estimate.
Where our models see it going: fair-value estimate $185.19, with a range of $166.50 to $212.97, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Semiconductor surge masks a cyclical trap
Picture a data centre rush where every new AI rack needs faster cables. Credo rides that wave with 157% revenue growth and 35% margins, yet our fair value sits 14% below the current price. The narrow moat and 22.6 times forward earnings leave little room for the next downturn.
The business clears our ethical screen and posts a solid 34% return on equity. Still, opportunity rating stays at none because the numbers already price in perfection. Strong buy notes from nineteen analysts do not change the fact that peak-cycle earnings often look cheap on a low multiple until they are not.
Semiconductor demand swings hard. When the cycle turns, those headline margins compress fast and investors who bought at the top learn the value trap lesson again. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Cayman Islands and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CRDO trades on NASDAQ (the company is based in Cayman Islands). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256. Insiders have been net sellers over the past quarter. Since the last review it its composite score eased.
2026-10-25Markdown · changed$172.81-3.2%Entry 9
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256. Insiders have been net sellers over the past quarter.
2026-10-18Accumulation$178.50-7.2%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 7.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256. Insiders have been net sellers over the past quarter.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading bullish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 16.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256. Insiders have been net sellers over the past quarter. Since the last review it its composite score eased.
2026-08-25Markup$230.43+13.7%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256.
2026-07-25Markup$202.68-19.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 19.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256.
2026-07-18Markup$250.81+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (18 analysts) rates it strong buy, with a mean price target of $256.
2026-07-03Markup$250.81+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$250.81Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
